查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401987

到 2030 年血管成形術球囊的全球市場預測：按類型、材料、適應症、最終用戶和地區進行分析

Angioplasty Balloons Market Forecasts to 2030 - Global Analysis By Type (Drug Eluting Balloons, Normal Balloons, Cutting Balloons, Scoring Balloons and Other Types), Material, Indication, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球血管成形球囊市場規模將達到 25 億美元，預計到 2030 年將達到 37 億美元，預測期內複合年成長率為 5.9%。

血管成形術球囊市場主要是由周邊動脈疾病和冠狀動脈疾病等心血管疾病的日益普及所推動的。這些球囊在治療動脈阻塞時必不可少，且血管成形術球囊的安全性和有效性已顯著提高，包括藥物塗層球囊（DCB）、球囊導管和更好材料的使用，透過該領域的不斷發展而提高。

根據2023 年2 月發表的《美國心臟病學會雜誌》，動脈粥狀硬化性心血管疾病的發生率對於10 年預測風險高的人來說，每1,000 人年的發生率為2.60；對於低風險但30 年預測風險高的人來說，每1,000 人年動脈粥狀硬化性心血管疾病的發生率為1.87。年預測風險為 0.32，10 年和 30 年預測風險較低的為 0.32。

心血管疾病盛行率增加

隨著全球心血管疾病發生率的增加，對血管成形術等手術的需求也不斷改變。這些治療的關鍵是血管成形術球囊，用於疏通狹窄或閉塞的動脈並恢復血流。由於醫療機構和供應商需要更多的血管成形球囊來滿足患者的需求，因此預計市場將隨著對血管成形術治療的需求不斷成長而發展。

高成本

對於患者來說，接受先進或客製化的球囊血管成形術可能成本高昂。經濟弱勢或保險不足地區的患者可能會面臨獲得這些服務的障礙，這可能會影響市場滲透率。如果患者和醫療保健相關人員選擇更實惠的選擇或傳統的球囊血管成形術而不是更先進和昂貴的球囊血管成形術，經濟問題可能會導致市場分裂。

快速引進尖端技術

先進技術的快速引進刺激了血管成形術球囊設計和製造的創新。公司有獎勵花錢進行研發，生產更複雜、更有用的氣球，包括藥物塗層氣球、刮傷氣球以及具有專有材料和塗層的氣球。成功開發並將最尖端科技融入血管成形術球囊的公司面臨競爭。透過提供滿足行業未滿足需求的創意解決方案，這些公司可能會佔領更大的市場佔有率。

與血管成形術相關的併發症

與血管成形術相關的血栓症、夾層和動脈損傷的風險可能使醫療相關人員對使用血管成形術球囊信心不足。這可能會導致採取更加謹慎的方法或降低這些設備的採用率。此外，複雜的案例可能會導致監管監督的加強或更徹底的評估，這可能會延遲新的血管成形球囊技術的核准過程。

COVID-19 的影響

在大流行的早期階段，世界各地的許多醫院和醫療機構推遲了選擇性手術，包括非緊急血管成形術。這是為了保護資源、減少患者接觸病毒並優先考慮 COVID-19 患者。這導致患者去醫院和診所的頻率降低，而對感染的恐懼導致心血管疾病診斷和血管成形術減少，阻礙了市場成長。

預計藥物釋放型球囊部分在預測期內將是最大的

由於藥物釋放型球囊的主要目的是降低血管再阻塞的發生率（即透過血管成形術治療的動脈血管再阻塞），因此該細分市場預計將出現良好的成長。透過防止動脈壁細胞增殖，藥物塗層減少了動脈再次收縮的機會。藥物釋放型球囊作為一種可行的治療選擇受到介入性心臟病專家的歡迎和青睞，特別是在支架放置不理想或難以安裝支架的小靜脈中。

聚氨酯領域預計在預測期內複合年成長率最高

預計聚氨酯領域在預測期內將出現最高的複合年成長率。聚氨酯的彈性和耐用性使其成為需要強度和彈性的醫療設備的合適材料。聚氨酯血管成形球囊可設計為具有可調節的充氣和放氣特性，從而在治療過程中實現精確的動脈擴張。由於其獨特的材料特性，聚氨酯血管成形術球囊仍然是大型血管成形術設備市場的領先選擇。

佔有率最大的地區

由於高齡化、不良飲食習慣、肥胖率增加和生活方式的改變，預計亞太地區在預測期內將佔據最大的市場佔有率。心血管疾病患者數量的增加增加了對血管成形術等介入性心臟病治療的需求。醫療設備的安全性和有效性由該地區各國的各種法律規範確保。為了在每個國家銷售產品，製造商必須遵守某些法規。

複合年成長率最高的地區：

由於介入性心臟病學設備的大幅增加，預計歐洲在預測期內將出現最高的複合年成長率。此外，歐洲心血管疾病的盛行率正在增加，這推動了對這些設備的需求，以及球囊成分、藥物塗層球囊和成像技術的不斷進步，這將提高血管成形術的有效性和安全性。生物可吸收支架和藥物釋放型球囊等新創新正在普及並推動市場成長。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球血管成形術球囊市場：依類型

  • 介紹
  • 藥物釋放型球囊
  • 一般氣球
  • 切割球囊
  • 球囊導管
  • 其他類型

第6章全球血管成形術球囊市場：依材料分類

  • 介紹
  • 聚氨酯
  • 矽膠胺甲酸乙酯共聚物
  • 尼龍
  • 其他材料

第7章全球血管成形術球囊市場：依適應症分類

  • 介紹
  • 血管新生
  • 腎動脈血管成形術
  • 末稍血管
  • 頸動脈血管成形術
  • 靜脈血管成形術
  • 冠狀動脈血管成形術
  • 其他適應症

第8章全球血管成形術球囊市場：依最終用戶分類

  • 介紹
  • 門診手術中心
  • 醫院
  • 導管實驗室
  • 專科診所
  • 診斷中心
  • 其他最終用戶

第9章全球血管成形術球囊市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Boston Scientific Corporation
  • Medtronic
  • Johnson & Johnson Services, Inc.
  • Abbott
  • Cardinal Health
  • Terumo Medical Corporation
  • B. Braun Melsungen AG
  • ENDOCOR GmbH
  • BIOTRONIK
  • Cook
  • Spectranetics
  • CR Bard, Inc.
  • AngioDynamics
  • Becton Dickinson
  • Biomerics
  • INFINITY Angioplasty Balloon
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation.
  • Hexacath
  • CTK biotech, Inc
Product Code: SMRC24507

According to Stratistics MRC, the Global Angioplasty Balloons Market is accounted for $2.5 billion in 2023 and is expected to reach $3.7 billion by 2030 growing at a CAGR of 5.9% during the forecast period. The angioplasty balloons market has been driven in large part by the increasing prevalence of cardiovascular illnesses, including peripheral artery disease and coronary artery disease. When treating artery blockages, these balloons are essential and the safety and effectiveness of angioplasty balloons have been improved by ongoing developments in the field, including the use of drug-coated balloons (DCB), scoring balloons, and better materials.

According to the Journal of the American College of Cardiology published in February 2023, the incidence rate of atherosclerotic cardiovascular disease per 1,000 person-years was 2.60 among those with raised 10-year predicted risk, 1.87 in those with low 10-year but elevated 30-year predicted risk and 0.32 in those with low 10-year and 30-year predicted risk.

Market Dynamics:

Driver:

Increasing prevalence of cardiovascular diseases

The necessity for procedures such as angioplasty develops in tandem with the global growth in the incidence of cardiovascular illnesses. An essential part of these treatments are angioplasty balloons, which are used to unblock constricted or obstructed arteries and restore blood flow. Because more angioplasty balloons are needed by healthcare institutions and providers to meet patient demands, the market is expected to develop as a result of the growing demand for angioplasty treatments.

Restraint:

High cost

Exorbitant expenses may restrict patients' access to sophisticated or customized balloon angioplasty treatments. Market penetration may be impacted by obstacles that patients in areas with little financial resources or insufficient insurance coverage may have when trying to access these services. Problems with affordability might result in market segmentation, when patients or medical professionals choose more affordable options or conventional balloon angioplasty techniques over more advanced, costly ones.

Opportunity:

Quick adoption of advanced technologies

Innovation in angioplasty balloon design and production is stimulated by the rapid adoption of sophisticated technology. In order to produce more sophisticated and useful balloons, such as those with coatings that are drug-coated, scored, or made of unique materials and coatings, it incentivizes businesses to spend money on research and development. Businesses with a competitive edge are those who develop and successfully incorporate cutting-edge technologies into their angioplasty balloons. By providing creative solutions that meet unmet demands in the industry, these businesses would be able to take a bigger chunk of the market

Threat:

Complications associated with angioplasty

The risks of thrombosis, dissection, or artery damage related to angioplasty operations may cause medical professionals to become less confident in their use of angioplasty balloons. This might result in a more circumspect approach or lower rates of these gadgets being adopted. Moreover, complicated cases may be subject to more stringent regulatory monitoring or carry out more thorough assessments, which could cause the clearance process for novel angioplasty balloon technology to lag.

COVID-19 Impact

Many hospitals and healthcare facilities around the world delayed elective operations, including non-urgent angioplasty procedures, during the early stages of the pandemic. In order to protect resources, reduce patient exposure to the virus, and provide priority to COVID-19 patients, this was done. Patients visited hospitals and clinics less frequently because to lockdown procedures and fear of infection, which decreased the amount of cardiovascular disease diagnoses and angioplasty procedures that followed thus hampered the growth of the market.

The drug eluting balloons segment is expected to be the largest during the forecast period

The drug eluting balloons segment is estimated to have a lucrative growth, because using drug-eluting balloons is primarily intended to decrease the incidence of restenosis, which is the re-narrowing of the angioplasty-treated artery. The medication coating lessens the chance that the artery may constrict again by preventing the proliferation of cells in the arterial wall. Drug-eluting balloons have become popular and well-liked by interventional cardiologists as a viable therapeutic option, particularly in situations where stent placement may not be optimal or in narrow veins where stent deployment may be difficult.

The polyurethane segment is expected to have the highest CAGR during the forecast period

The polyurethane segment is anticipated to witness the highest CAGR growth during the forecast period, because of its elasticity and durability, polyurethane is a good material to employ in medical devices that need to be strong and flexible. Polyurethane angioplasty balloons can be designed with regulated inflation and deflation characteristics, enabling accurate artery dilatation throughout the treatment. With their unique material qualities, polyurethane angioplasty balloons remain a viable option within the larger angioplasty devices market.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the aging population, poor diets, increased obesity rates, and changes in lifestyle in the Asia Pacific region. The number of CVD cases has increased, which has raised demand for interventional cardiology treatments like angioplasty. The safety and effectiveness of medical devices are guaranteed by the various regulatory frameworks that each nation in the area has for them. In order to market their products in their different countries, manufacturers must adhere to certain restrictions.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period; owing to the considerable increasing interventional cardiology equipment. Moreover, Europe was seeing an increase in the prevalence of cardiovascular disorders, which was driving demand for these devices and the constant progress in balloon composition, drug-coated balloons, and imaging technology was improving angioplasty operations' efficacy and safety. Novelties like bioresorbable scaffolds and drug-eluting balloons were becoming more popular which drives the growth of the market.

Key players in the market:

Some of the key players profiled in the Angioplasty Balloons Market include Boston Scientific Corporation, Medtronic, Johnson & Johnson Services, Inc., Abbott, Cardinal Health, Terumo Medical Corporation, B. Braun Melsungen AG, ENDOCOR GmbH, BIOTRONIK, Cook, Spectranetics, C. R. Bard, Inc., AngioDynamics, Becton Dickinson, Biomerics, INFINITY Angioplasty Balloon, MicroPort Scientific Corporation, Nipro Medical Corporation., Hexacath and CTK biotech, Inc

Key Developments:

In November 2023, Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept

In November 2023, Medtronic announces FDA approval of minimally invasive device to treat hypertension. Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology

In September 2023, Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. The WATCHMAN FLX Pro device is built upon the proven safety and procedural performance

Types Covered:

  • Drug Eluting Balloons
  • Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Other Types

Materials Covered:

  • Polyurethane
  • Silicone Urethane Co-Polymers
  • Nylon
  • Other Materials

Indications Covered:

  • Angioplasty
  • Renal Artery Angioplasty
  • Peripheral Angioplasty
  • Carotid Angioplasty
  • Venous Angioplasty
  • Coronary Angioplasty
  • Other Indications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Cath Labs
  • Specialty Clinics
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Angioplasty Balloons Market, By Type

  • 5.1 Introduction
  • 5.2 Drug Eluting Balloons
  • 5.3 Normal Balloons
  • 5.4 Cutting Balloons
  • 5.5 Scoring Balloons
  • 5.6 Other Types

6 Global Angioplasty Balloons Market, By Material

  • 6.1 Introduction
  • 6.2 Polyurethane
  • 6.3 Silicone Urethane Co-Polymers
  • 6.4 Nylon
  • 6.5 Other Materials

7 Global Angioplasty Balloons Market, By Indication

  • 7.1 Introduction
  • 7.2 Angioplasty
  • 7.3 Renal Artery Angioplasty
  • 7.4 Peripheral Angioplasty
  • 7.5 Carotid Angioplasty
  • 7.6 Venous Angioplasty
  • 7.7 Coronary Angioplasty
  • 7.8 Other Indications

8 Global Angioplasty Balloons Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Cath Labs
  • 8.5 Specialty Clinics
  • 8.6 Diagnostic Centers
  • 8.7 Other End Users

9 Global Angioplasty Balloons Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Boston Scientific Corporation
  • 11.2 Medtronic
  • 11.3 Johnson & Johnson Services, Inc.
  • 11.4 Abbott
  • 11.5 Cardinal Health
  • 11.6 Terumo Medical Corporation
  • 11.7 B. Braun Melsungen AG
  • 11.8 ENDOCOR GmbH
  • 11.9 BIOTRONIK
  • 11.10 Cook
  • 11.11 Spectranetics
  • 11.12 C. R. Bard, Inc.
  • 11.13 AngioDynamics
  • 11.14 Becton Dickinson
  • 11.15 Biomerics
  • 11.16 INFINITY Angioplasty Balloon
  • 11.17 MicroPort Scientific Corporation
  • 11.18 Nipro Medical Corporation.
  • 11.19 Hexacath
  • 11.20 CTK biotech, Inc

List of Tables

  • Table 1 Global Angioplasty Balloons Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Angioplasty Balloons Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Angioplasty Balloons Market Outlook, By Drug Eluting Balloons (2021-2030) ($MN)
  • Table 4 Global Angioplasty Balloons Market Outlook, By Normal Balloons (2021-2030) ($MN)
  • Table 5 Global Angioplasty Balloons Market Outlook, By Cutting Balloons (2021-2030) ($MN)
  • Table 6 Global Angioplasty Balloons Market Outlook, By Scoring Balloons (2021-2030) ($MN)
  • Table 7 Global Angioplasty Balloons Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Angioplasty Balloons Market Outlook, By Material (2021-2030) ($MN)
  • Table 9 Global Angioplasty Balloons Market Outlook, By Polyurethane (2021-2030) ($MN)
  • Table 10 Global Angioplasty Balloons Market Outlook, By Silicone Urethane Co-Polymers (2021-2030) ($MN)
  • Table 11 Global Angioplasty Balloons Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 12 Global Angioplasty Balloons Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 13 Global Angioplasty Balloons Market Outlook, By Indication (2021-2030) ($MN)
  • Table 14 Global Angioplasty Balloons Market Outlook, By Angioplasty (2021-2030) ($MN)
  • Table 15 Global Angioplasty Balloons Market Outlook, By Renal Artery Angioplasty (2021-2030) ($MN)
  • Table 16 Global Angioplasty Balloons Market Outlook, By Peripheral Angioplasty (2021-2030) ($MN)
  • Table 17 Global Angioplasty Balloons Market Outlook, By Carotid Angioplasty (2021-2030) ($MN)
  • Table 18 Global Angioplasty Balloons Market Outlook, By Venous Angioplasty (2021-2030) ($MN)
  • Table 19 Global Angioplasty Balloons Market Outlook, By Coronary Angioplasty (2021-2030) ($MN)
  • Table 20 Global Angioplasty Balloons Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 21 Global Angioplasty Balloons Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Angioplasty Balloons Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 23 Global Angioplasty Balloons Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 Global Angioplasty Balloons Market Outlook, By Cath Labs (2021-2030) ($MN)
  • Table 25 Global Angioplasty Balloons Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 26 Global Angioplasty Balloons Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 27 Global Angioplasty Balloons Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.